Publications by authors named "E P Mylonakis"
Unlabelled: is a high-priority organism for the development of new antibacterial treatments. We found that the antimalarial medication mefloquine (MFQ) permeabilized the bacterial cell membrane of , decreased membrane fluidity, and caused physical injury to the membrane. MFQ also maintained activity across different pH conditions (PH range 5-8).
View Article and Find Full Text PDFBackground: Perceived discrimination and medical mistrust are barriers to care that impact both individual and population health.
Objective: This study aims to characterize the prevalence of perceived racial or ethnic discrimination in healthcare as well as mistrust in the medical system and explore their associations with race and ethnicity.
Design: Cross-sectional study of nationally representative data from the Health Information National Trends Survey (fielded March-November 2022).
Article Synopsis
- The study investigates the impact of a new diabetes treatment on patient outcomes, focusing on both metabolic control and quality of life.
- Researchers conducted a multicenter trial with diverse participants to ensure the findings are applicable to a broad population.
- Results indicated significant improvements in key health markers, suggesting that the new treatment could be a game-changer in diabetes management.